MedPath

Psychometric properties of the De Morton Mobility Index (DEMMI) in older individuals with cognitive impairment in inpatient geriatric care

Conditions
Geriatric inpatients with cognitive impairment
G00-G99
Diseases of the nervous system
Registration Number
DRKS00005591
Lead Sponsor
Hochschule für Gesundheit Bochum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
153
Inclusion Criteria

Acute geriatric inpatient
- Admission within the last 7 days
- Mini Mental State Examination score =24

Exclusion Criteria

- contra-indication for mobilization
- Isolated due to infection
- Imminent death
- Blindness
- Deafness
- Discharged before assessment
- Non-German speaker
- In state of coma or severely reduced vigilance
- Akute severe organ failure
- Akute severe psychiatric condition
- Any other medical/physical condition where a mobility examination could worsen the medical state or where it would highly stress the participant.

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Convegent Validity: Hypothesis testing with respect to correlations between the index test (DEMMI) and other validated measures of mobility (Hierarchical Assessment of Balance and Mobility, Functional Ambulation Categories, Performance Oriented Mobility Assessment, gait speed, Timed Up And Go Test, 2 Minute Walk Test, Short Physical Performance Battery, Barthel Index-Mobility).
Secondary Outcome Measures
NameTimeMethod
1) Test-retest reliability (level of agreement betwen 2 test results = Intra Class Coefficient [ICC]).<br><br>2) Feasibility (time to administer the DEMMI, number of adverse events).<br><br>3) Responsiveness-to-change: Hypothesis testing based on correlations between changes in the index test (DEMMI) and the reference tests. Area under the curve (AUC) with respect to a change in mobility levels (yes/no based on the global rating of change).<br><br>4) Interpretability: floor- and ceiling-effects will be reported descriptively.<br><br>5) Unidimensionality: Rasch analysis.
© Copyright 2025. All Rights Reserved by MedPath